1 ct brain development an important biomedical
objective.
2 rolling to address secondary and exploratory
objectives.
3 compared nocebo-related subjective AEs with
objective AEs and investigated factors potentially assoc
4 Objective AEs were defined as hepatic and objective musc
5 etworks from a set of reactions is a central
objective and an ongoing challenge in the field of syste
6 ve cohort study assessed whether a validated
objective and individual-level housing-based SES index (
7 Based on wavefront sensor images an
objective and quantitative method is presented for chara
8 However,
objective and worldwide data regarding this topic are la
9 l supplement to enhance military performance
objectives and to provide optimal exercise training and
10 platform, delivery timing, and health system
objective)
and did one-way and probabilistic sensitivity
11 that our colour constancy mechanism is real (
objective)
and primarily attuned to correct for the colo
12 e disease control, as sensors are sensitive,
objective,
and highly available for disease assessment.
13 llution interventions in exposed populations.
Objectives:
Apply G-computation to estimate hypothetical
14 turned out to be a fast, cost-effective and
objective approach for high throughput analytical screen
15 this study, cluster analysis was used as an
objective approach for phenotyping participants based on
16 Objective assessment has been undertaken with actigraphy
17 organ dysfunction syndrome, compared to the
objective assessment of multiple organ dysfunction syndr
18 Scanning was performed using a 40x dry lens
objective automated slide scanner.
19 m Monitor reported significant reductions in
objective binge-eating days (beta=-0.66, 95% CI=-1.06, -
20 Furthermore, this
objective can be exactly achieved by a network with reci
21 These subjective and
objective changes in temporal memory are also related to
22 A favorable impact on both perceived and
objective cognitive performance during treatment was obs
23 a unique cohort of 1,196 children with both
objective,
court-documented evidence of maltreatment and
24 A standard,
objective definition of de-escalation applied to electro
25 red the barrier to accessing cost-efficient,
objective detection methodologies.
26 ces in pulmonary arterial hypertension (PAH).
Objectives:
Determine effects of race/ethnicity and ance
27 mass spectrometry imaging (MSI) can support
objective diagnosis in minutes using a routine frozen ti
28 ost-effectiveness of implementing a stepwise
objective diagnostic verification algorithm among patien
29 ptom assessments were estimated lowlier than
objective finding assessments.
30 Here, we define a method for
objective function estimation of arbitrary computational
31 ation procedure sets the connectivity of the
objective function in the target system state on a fixed
32 dels with/without an outer-level (community)
objective function.
33 he past 25 years, progress in realizing this
objective has been transformed by advances in technology
34 Objective:
Here, we sought to determine how cytoskeletal
35 disease is typically slowly progressive, and
objective,
imaging-based biomarkers are critically neede
36 st photosynthetic productivity remains a key
objective in global biology.
37 h and, in many respects, represents the main
objective in the context of an Ecosystem Approach, with
38 is to use multiple energy functions as multi-
objectives in an effort to correct the potential inaccur
39 making them unlikely to achieve conservation
objectives in rural coastal economies.
40 Our primary
objectives in this study were to evaluate whether the vo
41 Secondary
objectives included feasibility of timely central pathol
42 Secondary
objectives included tolerance, compliance to oral supple
43 The exploratory
objectives included tracking of edited T cells.
44 riety of available data sources towards this
objective,
including electronic health records, intraope
45 Secondary
objectives investigated potential sex differences in MRI
46 Our
objective is that this framework will improve the qualit
47 heart disease (CHD) patients, whose primary
objective is to compare the effect of 2 healthy dietary
48 The primary
objective is to determine in the PARTNER 2 trial (The Pl
49 The
objective is to determine the magnitude of the shift in
50 Our
objective is to develop and use a computational method f
51 A secondary
objective is to evaluate the radiation exposure to the s
52 Our
objective is to foster development of community-driven d
53 The primary
objective is to identify biomarkers of severe RSV acute
54 Our
objective is to understand the molecular determinants of
55 Breath shields attached to the
objective lens arm were better barriers than those of co
56 ll-thickness colon images, viewed with a 10x
objective lens, were as large as 4 x 5 mm(2).
57 scillations inside the magnetic field of the
objective lens.
58 instrument that combines an open-top, single-
objective light sheet fluorescence microscope with an at
59 ometer-derived sleep midpoint was used as an
objective measure of morningness-eveningness preference.
60 ant allocation was implemented as a fair and
objective measure to prioritize patients based upon dise
61 e evaluation of clinical trial data using an
objective measurement of vascular severity may help to d
62 t there is no evidence, using nonvolitional,
objective measurements, that physical therapy increases
63 showing improvements in subjective and some
objective measures of HF.
64 t records, risk of psychopathology linked to
objective measures was minimal in the absence of subject
65 of dependence or opioid withdrawal by AEs or
objective measures.
66 The new,
objective method showed a reduction in corneal nerve par
67 and GABA(A) receptor densities can identify
objective molecular markers in ASD.
68 Objective AEs were defined as hepatic and
objective muscular AEs.
69 The
objective of a shield immunity strategy is to help to su
70 oils collected in the AHHS, with the primary
objective of gaining a better understanding of determina
71 in an asymptomatic well-population with the
objective of identifying cancer biomarkers could allow e
72 A secondary
objective of MODIFY I/II was to assess bezlotoxumab's ef
73 maging technique has been developed with the
objective of obtaining not only a functional analysis of
74 The
objective of our research was to evaluate the diagnostic
75 The
objective of our study is to describe changes in cardiac
76 The primary
objective of our study was to derive and evaluate a comb
77 One primary
objective of synthetic biology is to improve the sustain
78 The
objective of the current study was to define lung injury
79 The
objective of the current study was to determine how libr
80 The main
objective of the current study was to determine whether
81 The
objective of the current study was to investigate how th
82 The
objective of the present study was to assess the extent
83 The
objective of the present study was to compare the prepar
84 The
objective of the present study was to evaluate the 2016
85 A major
objective of the present study was to identify the mecha
86 The
objective of the study was to assess the impact of IBS-D
87 Specific
objective of the study was to assess the impact of PCG m
88 The main
objective of the study was to determine the prevalence o
89 The
objective of the study was to determine whether high aff
90 The
objective of the study was to investigate if SKAP2 has a
91 d be tailored to each situation based on the
objective of the surveillance program.
92 A secondary
objective of the trial was to assess angina-related heal
93 The
objective of this analysis is to evaluate the evidence r
94 The
objective of this article is to describe an innovative m
95 The
objective of this mixed-methods study was to understand
96 The
objective of this paper is to develop efficient algorith
97 The
objective of this retrospective study was to assess the
98 The
objective of this review is to summarize the up-to-date
99 The
objective of this review was to compare the efficacy and
100 The
objective of this study is to analyze noise patterns dur
101 The
objective of this study is to assess the implications of
102 The
objective of this study is to compare HCR and convention
103 The
objective of this study is to determine whether a hospit
104 Therefore, the
objective of this study is to elucidate the extracellula
105 The
objective of this study is to evaluate the pre-clinical
106 The
objective of this study is to make strong and durable de
107 The
objective of this study is to predict T2D risk using ful
108 The
objective of this study was to analyze the outcomes of T
109 The
objective of this study was to assess the clinical impac
110 The
objective of this study was to assess the distribution,
111 The
objective of this study was to assess the effects of set
112 The
objective of this study was to assess the efficacy and s
113 The
objective of this study was to characterize antigenicall
114 The
objective of this study was to characterize the effects
115 The
objective of this study was to characterize the patterns
116 ility of these compounds from chocolate, the
objective of this study was to characterize their profil
117 The
objective of this study was to compare (18)F-DPA714, a s
118 The main
objective of this study was to compare bioactive compoun
119 The
objective of this study was to compare the diversity and
120 The
objective of this study was to compare the ratio of rena
121 The
objective of this study was to construct and evaluate ri
122 The primary
objective of this study was to describe trends in US out
123 The
objective of this study was to determine bacterial etiol
124 The
objective of this study was to determine the performance
125 The
objective of this study was to determine the relationshi
126 The
objective of this study was to determine the result repr
127 The
objective of this study was to develop a comprehensive p
128 The
objective of this study was to develop a methodology to
129 The
objective of this study was to develop a novel drug deli
130 The
objective of this study was to evaluate different strate
131 The
objective of this study was to evaluate if glyphosate, 2
132 The
objective of this study was to evaluate the effect of ri
133 The
objective of this study was to evaluate the effects of g
134 The
objective of this study was to evaluate the thickness an
135 The
objective of this study was to evaluate the volatile com
136 The
objective of this study was to examine ATP level and PG
137 The
objective of this study was to examine early lung transp
138 The
objective of this study was to generate clozapine-specif
139 The main
objective of this study was to identify genetic loci lin
140 The
objective of this study was to investigate associations
141 The
objective of this study was to investigate if microgravi
142 The
objective of this study was to investigate the effect of
143 The
objective of this study was to investigate the effect of
144 The
objective of this study was to investigate the effect of
145 The
objective of this study was to investigate the underlyin
146 The
objective of this study was to prospectively assess its
147 The primary
objective of this study was to provide a detailed and ro
148 The
objective of this study was to provide a mechanistic ana
149 The
objective of this study was to provide evidence for peri
150 The
objective of this study was to quantify how much the pri
151 Therefore, the
objective of this study was to quantify the effect of ma
152 The
objective of this study was to quantify the number of se
153 The
objective of this study was to test a novel neuromodulat
154 The
objective of this two-sample Mendelian randomization (MR
155 The
objective of this work is to describe a novel platform f
156 The
objective of this work was to classify the major phenoli
157 The main
objective of this work was to conduct the preclinical ev
158 The overall
objective of this work was to enable rapid (<30 min), se
159 The
objective of this work was to investigate the impact of
160 ough extensive simulations covering both the
objectives of accurate parameter estimation and model se
161 The
objectives of our study were to investigate intervention
162 The
objectives of the present study are to evaluate levels o
163 The
objectives of the present study were to provide addition
164 Hence, the
objectives of the study were to (i) design and build a n
165 The primary
objectives of this study were to (1) evaluate whether gr
166 The
objectives of this study were to assess the reporting qu
167 The
objectives of this study were to describe early occurren
168 Background The
objectives of this study were to develop and test in rea
169 The
objectives of this study were to examine PFAS levels in
170 The
objectives of this study were to investigate how shift w
171 Therefore, the
objectives of this work are threefold.
172 Therefore, the
objectives of this work were to adapt the isolated Lange
173 Objective partial responses were observed in 66 (48%; 95
174 d automatic quantification offers a feasible
objective quality control measure for RCM imaging.
175 ence of cognitive impairment was higher with
objective rather than subjective assessments (54% [95% c
176 Achieving military mission
objectives requires high levels of performance from Airm
177 coma, five (12%; 4-26) of 42 patients had an
objective response (all partial responses) and 14 (33%;
178 en (26%; 95% CI 13-42) of 39 patients had an
objective response (all partial responses) by 6 months;
179 At 6 months, four patients (5%) achieved an
objective response (all partial responses).
180 point was the percentage of patients with an
objective response (complete or partial response) as ass
181 osarcoma, a dual primary endpoint of 6-month
objective response and 6-month non-progression was asses
182 cluded the proportion of patients who had an
objective response per RECIST 1.1 and was assessed in al
183 The primary end point was
objective response rate (ORR) at 24 weeks (ORR(Wk24)); s
184 The
objective response rate (ORR) for single-agent anti-prog
185 mab plus dabrafenib and trametinib led to an
objective response rate (ORR) of 78%, including 44% comp
186 The primary endpoint was
objective response rate (ORR); the null hypothesis (<= 5
187 mplete response and seven partial responses (
objective response rate 19%, 95% CI 9-34).
188 Objective response rate and progression-free survival pe
189 The primary endpoint was
objective response rate based on the 2007 International
190 e primary endpoint was investigator-assessed
objective response rate by RECIST in cohort one.
191 Primary endpoints were confirmed
objective response rate in all patients who received the
192 The primary end point was
objective response rate per RECIST v1.1.
193 At a median follow-up of 12 months, the
objective response rate to ipilimumab and nivolumab was
194 The
objective response rate to pembrolizumab was 23% (nine p
195 The
objective response rate was 69% (95% CI 53-82; 31 of 45
196 ter the first cycle had significantly higher
objective response rates and longer progression-free and
197 ability, and the proportion of patients with
objective response to pembrolizumab for each tumour type
198 Objective response was 4% and clinical benefit rate (CR
199 ed to tumors and, in one patient, induced an
objective response with regression of bone metastatic le
200 ary null hypothesis was equal probability of
objective response within 6 months of random allocation
201 primary endpoint for Ewing sarcoma was best
objective response within 6 months of treatment onset; f
202 in the efficacy-evaluable population had an
objective response.
203 MSI-H/MMR-D status were not associated with
objective response.
204 eceived tafasitamab plus lenalidomide had an
objective response: 34 (43%; 32-54) had a complete respo
205 The other seven patients with
objective responses had microsatellite stable tumors.
206 Objective responses were seen in 22 (41.5%) of 53 patien
207 le patients in the basket expansion achieved
objective responses.
208 riverine flood risk management using a multi-
objective robust decision-making framework in the face o
209 (non-radiographic axial spondyloarthritis),
objective signs of inflammation (via MRI or C-reactive p
210 Findings held controlling for
objective socioeconomic status both statistically and by
211 s and scientists with an accurate, rapid and
objective technique for quantification of lens transmitt
212 The
objective tests were scores for best-corrected visual ac
213 ing has the potential to be more precise and
objective than histological evaluation and may identify
214 Objective:
To determine if vascular aging before the ind
215 Objective:
To determine the mechanisms of IL-10 (interle
216 Objective:
To develop an approach to identify additional
217 Objective:
To identify candidate causal genes for IR, we
218 expense of increasing the risk of pneumonia.
Objectives:
To assess the relationship between the prese
219 y disease risk and severity is controversial.
Objectives:
To comprehensively evaluate the effects of r
220 transcriptome characterization of CF sputum.
Objectives:
To define the transcriptional profile of spu
221 rare and largely unknown complication of NF1.
Objectives:
To describe characteristics and outcomes of
222 t, its effect on lung health remains unclear.
Objectives:
To determine the effect of SZ-AATD on spirom
223 osis (CF) and other mucoobstructive diseases.
Objectives:
To determine the effects of TMEM16A potentia
224 r intrauterine inflammation is controversial.
Objectives:
To determine whether antenatal or postnatal
225 s characterized as a distinct ARDS phenotype.
Objectives:
To determine whether such Crs-based phenotyp
226 N1, and N2 or N3 (N2|3) disease is important.
Objectives:
To develop a prediction model for estimating
227 nd optimize surveillance regimens are needed.
Objectives:
To develop and validate a deep learning meth
228 an alternative strategy to correct acidemia.
Objectives:
To evaluate feasibility, safety, and effecti
229 VD could depend on specific patient profiles.
Objectives:
To evaluate the effect of OSA on cardiovascu
230 nt regimen for latent tuberculosis infection.
Objectives:
To evaluate the effects of INH preventive th
231 wed by regeneration of normalized epithelium.
Objectives:
To evaluate the feasibility, safety, and ini
232 1 treatment can prevent BPD or PH is unknown.
Objectives:
To evaluate whether postnatal treatment with
233 to optimally organize and manage their care.
Objectives:
To identify a set of effective care practice
234 n be predicted based on genomic determinants.
Objectives:
To identify genomic alterations associated w
235 jectories of disease progression challenging.
Objectives:
To identify subtypes of patients with COPD w
236 y have lasting effects on respiratory health.
Objectives:
To investigate lung function at ages 8 and 1
237 harge delay on patient outcomes is uncertain.
Objectives:
To investigate the association between disch
238 remorbid low/high blood pressure are unknown.
Objectives:
To investigate the relationship between prem
239 (RCTs) on the effects of eHealth are scarce.
Objectives:
To investigate whether a home monitoring pro
240 lls were at elevated levels in such patients.
Objectives:
To measure ABC-like cell percentages in pati
241 onary disease and a history of exacerbations.
Objectives:
To understand whether inhaled corticosteroid
242 holding great promise for development as an
objective tool for surgical planning, patient education,
243 demonstrated the best discrimination of the
objective tools (SORT Area Under Receiver Operating Char
244 t continuing nonpandemic research should use
objective,
transparent criteria considering several aspe
245 change scenarios meeting the Paris Agreement
objectives using a climate-dependent-metapopulation mode
246 tion in human lungs has not been established.
Objectives:
Using a nonhuman primate (NHP) model of TB,
247 The primary
objective was met in six of the nine patients at 12 mont
248 The primary
objective was the rate of partial hematologic response (
249 Our
objective was to ablate proliferating osteoblast lineage
250 My
objective was to analyze recent trials in infectious dis
251 Our
objective was to ascertain whether PCSK9 inhibition redu
252 A secondary
objective was to assess anthropogenically derived artifi
253 Our
objective was to assess gait asymmetry (GA) and bilatera
254 Our
objective was to assess the antipneumococcal antibody ti
255 Our
objective was to characterize the relationship between r
256 Our
objective was to compare functional and safety outcomes
257 The primary
objective was to compare pimodivir pharmacokinetics in e
258 Our
objective was to define the prevalence and correlates of
259 Our
objective was to demonstrate that asymptomatic nasophary
260 The primary
objective was to describe the OCT features at the margin
261 The
objective was to describe the relationship between hand
262 Our
objective was to describe trends and variations in Impel
263 f Gulf War Veterans are overweight, a second
objective was to determine if a high fat diet (HF) would
264 The primary
objective was to determine if dietary nervonic acid cont
265 The
objective was to determine if the asymptomatic plants ha
266 Our
objective was to determine patient-reported barriers to
267 The primary
objective was to determine whether the cumulative incide
268 Our
objective was to develop a comprehensive MRI technique f
269 Our
objective was to develop macaque trophoblast stem cells
270 The primary
objective was to establish a recommended phase II dose (
271 The
objective was to estimate performance of assays to detec
272 The primary
objective was to evaluate the application of enzyme-link
273 The
objective was to evaluate the effect of salt-coatings on
274 A secondary
objective was to evaluate the effect that local phenotyp
275 Our
objective was to evaluate the independent prognostic val
276 Our
objective was to evaluate three sample-to-answer molecul
277 The second
objective was to evaluate whether preclinical mutation c
278 The primary
objective was to examine baseline clinical and DAT imagi
279 Our
objective was to examine the effect of low- and moderate
280 Our
objective was to examine the relationship between sTREM2
281 Our
objective was to explore the performance of risk predict
282 Our
objective was to identify the characteristics of lipid d
283 The
objective was to identify the chemical compounds that wo
284 Our
objective was to investigate the lesion detection rate o
285 Our
objective was to investigate the potential of MRL/MpJ te
286 y examined these risks separately; thus, our
objective was to simultaneously evaluate AKI and CDI ris
287 Our
objective was to use (18)F-FDG PET/CT to identify a high
288 non-IgE-mediated allergies, and part of its
objectives was to establish diagnosis and management of
289 that measures the velocity of moving tissue.
Objectives:
We applied this technique to the diaphragm t
290 itate vaccine development is urgently needed.
Objectives:
We evaluated the feasibility, safety, and im
291 complement activity, during critical illness.
Objectives:
We examined the function and key components
292 pment of idiopathic pulmonary fibrosis (IPF).
Objectives:
We sought to decipher the transcriptome of f
293 Primary
objectives were assessments and comparisons of safety up
294 The primary
objectives were to assess the safety and evaluate the ef
295 The primary
objectives were to determine the incidence of serious ca
296 Phase 1 primary
objectives were to determine the maximum tolerated dose
297 Study
objectives were to estimate genetic parameters, identify
298 Our
objectives were to quantify variation in a suite of trai
299 otonin levels in brain synapses is a primary
objective when treating major depressive disorder-a dise
300 ctured approach to aligning a clinical trial
objective with the study design, including endpoints and